Lower Limb Claudication Due to Bilateral Iliac Artery Occlusive Disease: The Case for Iliac Stenting and Femorofemoral Crossover Bypass

  • Jean-Baptiste Ricco
  • Olivier Page
Chapter

Abstract

A 54-year-old man presents to your clinic complaining of bilateral rest pain of the toes and a past medical history of cramping pain in his calves when he walks. The patient had a 30-pack year smoking history and remains an active smoker. Clinical examination revealed an absent left femoral pulse and a diminished right femoral pulse. Popliteal and pedal pulses were absent on both sides. Bilateral carotid bruits were noted. Palpation of the abdominal aorta was normal. The patient was also moderately breathless on minimal exertion and had a chronic productive cough. The ECG was normal, a chest x-ray showed evidence for chronic obstructive pulmonary disease (COPD). FEV1 was 950 mL not enhanced after inhalation of bronchodilators. The patient was currently taking medications for hypertension and elevated cholesterol.

The patient had a Duplex-scan with measurements of the ABI that was 0.40 on the right side and of 0.29 on the left. The Duplex showed an occlusion of the left external iliac artery and significant stenoses of the right common and external iliac arteries with occlusion of both superficial femoral arteries. The patient had also mild bilateral carotid artery stenosis.

The duplex scan was followed by digital percutaneous subtraction contrast angiography that showed an occlusion of the left external iliac artery and a significant stenosis of the right common and external iliac arteries. Severe occlusive lesions were also seen in both common femoral arteries (Figs. 18.1 18.3). The superficial femoral artery was occluded on both sides. Significant lesions of the crural arteries were also present (not shown).

Keywords

Chronic Obstructive Pulmonary Disease Iliac Artery Superficial Femoral Artery Ankle Brachial Index Critical Limb Ischaemia 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Criqui MH, Langer RD, Fronek A, et al. Mortality over a period of 10 years in patients with peripheral arterial disease. N Engl J Med. 1992;326:381-386.PubMedCrossRefGoogle Scholar
  2. 2.
    McKenna M, Wolfson S, Kuller L. The ratio of ankle and arm arterial pressure as an independent predictor of mortality. Atherosclerosis. 1991;87:119-128.PubMedCrossRefGoogle Scholar
  3. 3.
    Murabito JM, Evans JC, Nieto K, Larson MG, Levy D, Wilson PW. Prevalence and clinical correlates of peripheral arterial disease in the Framingham Offspring Study. Am Heart J. 2002;143:961-965.PubMedCrossRefGoogle Scholar
  4. 4.
    Howell MA, Colgan MP, Seeger RW, Ramsey DE, Sumner DS. Relationship of severity of lower limb peripheral vascular disease to mortality and morbidity: a six-year follow-up study. J Vasc Surg. 1989;9:691-696.PubMedGoogle Scholar
  5. 5.
    Adam DJ, Beard JD, Cleveland T, et al. Bypass versus angioplasty in severe ischaemia of the leg (BASIL): multicentre, randomised controlled trial. Lancet. 2005;366:1925-1934.PubMedCrossRefGoogle Scholar
  6. 6.
    Stoyioglou A, Jaff MR. Medical treatment of peripheral arterial disease: a comprehensive review. J Vasc Interv Radiol. 2004;15:1197-1207.PubMedCrossRefGoogle Scholar
  7. 7.
    Schanzer A, Mega J, Meadows J, Samson RH, Bandyk DF, Conte MS. Risk stratification in critical limb ischaemia: derivation and validation of a model to predict amputation-free survival using multicenter surgical outcomes data. J Vasc Surg. 2008;48:1464-1471.PubMedCrossRefGoogle Scholar
  8. 8.
    Schanzer A, Goodney PP, YouFu L, et al. Validation of the PIII CLI Risk Score for the prediction of amputation-free survival in patients undergoing surgical bypass for critical limb ischaemia. J Vasc Surg. 2009;50:769-775.PubMedCrossRefGoogle Scholar
  9. 9.
    Rose SC. Noninvasive vascular laboratory for evaluation of peripheral arterial occlusive disease. Part II. Clinical applications: chronic atherosclerotic, lower extremity ischaemia. J Vasc Interv radiol. 2000;11:1257-1275.PubMedCrossRefGoogle Scholar
  10. 10.
    Brewster DC. Current controversies in the management of aortoiliac occlusive disease. J Vasc Surg. 1997;25:365-379.PubMedCrossRefGoogle Scholar
  11. 11.
    Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA. Fowkes FGR on behalf of the TASC II working group. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). Eur J Vasc Endovasc Surg. 2007;33:S54-S57.CrossRefGoogle Scholar
  12. 12.
    Pursell R, Sideso E, Magee TR, Galland RB. Critical appraisal of femorofemoral crossover grafts. Br J Surg. 2005;92:565-569.PubMedCrossRefGoogle Scholar
  13. 13.
    Kim YW, Lee JH, Kim HG, Huh S. Factors affecting the long-term patency of crossover femorofemoral bypass graft. Eur J Vasc Endovasc Surg. 2005;30:376-380.PubMedCrossRefGoogle Scholar
  14. 14.
    AbuRahma AF, Robinson PA, Cook CC, Hopkins ES. Selecting patients for combined femorofemoral bypass grafting and iliac balloon angioplasty and stenting for bilateral iliac disease. J Vasc Surg. 2001;33:S93-S99.PubMedCrossRefGoogle Scholar
  15. 15.
    Ricco JB, Probst H, French University Surgeons Association. Long-term results of a multicenter randomized study on direct versus crossover bypass for unilateral iliac artery occlusive disease. J Vasc Surg. 2008;47:45-53.PubMedCrossRefGoogle Scholar
  16. 16.
    Porter JM, Eidemiller LR, Dotter CT, Rosch J. Vetto RM. Combined arterial dilatation and femorofemoral bypass for limb salvage. Surg Gynecol Obstet. 1973;137:409-412.PubMedGoogle Scholar
  17. 17.
    Walker PJ, Harris JP. May J. Combined percutaneous transluminal angioplasty and extra-anatomic bypass for symptomatic unilateral iliac occlusion with contralateral iliac artery stenosis. Ann Vasc Surg. 1991;5:209-217.PubMedCrossRefGoogle Scholar
  18. 18.
    Shah RM, Peer RM, Upson JF, Ricotta JJ. Donor iliac angioplasty and crossover femorofemoral bypass. Am J Surg. 1992;164:295-298.PubMedCrossRefGoogle Scholar
  19. 19.
    Perler BA, Williams GM. Does donor iliac artery percutaneous transluminal angioplasty or stent placement influence the results of femorofemoral bypass. Analysis of 70 consecutive cases with long-term follow-up. J Vasc Surg. 1996;24:363-370.PubMedCrossRefGoogle Scholar
  20. 20.
    Schneider JR, Besso SR, Walsh DB, Zwolack RM, Cronenwett JL. Femorofemoral versus aortofemoral bypass. Outcome and hemodynamic results. J Vasc Surg. 1994;19:43-57.PubMedCrossRefGoogle Scholar
  21. 21.
    Criado E, Burnham SJ, Tinsley EA, Johnson G, Keagy BA. Femorofemoral bypass graft: analysis of patency and factors influencing long-term outcome. J Vasc Surg. 1993;18:495-505.PubMedCrossRefGoogle Scholar
  22. 22.
    Brewster DC, Cambria RF, Darling RC, et al. Long-term results of combined iliac balloon angioplasty and distal surgical revascularization. Ann Surg. 1989;210:324-331.PubMedCrossRefGoogle Scholar
  23. 23.
    Marin ML, Veith FJ, Sanchez LA, et al. Endovascular aortoiliac grafts in combination with standard infrainguinal arterial bypasses in the management of limb-threatening ischemia. J Vasc Surg. 1995;22:316-325.PubMedCrossRefGoogle Scholar
  24. 24.
    Cynamon J, Marin ML, Veith FJ, et al. Stent-graft repair of aortoiliac occlusive disease coexisting with common femoral artery disease. J Vasc Interv Radiol. 1997;8:19-26.PubMedCrossRefGoogle Scholar
  25. 25.
    Heart Protection Study Collaborative Group. Randomised trial of the effects of cholesterol-lowering with simvastatin on peripheral vascular and other major vascular outcomes in 20, 536 people with peripheral arterial disease and other high-risk conditions. J Vasc Surg. 2007;45:645-654.CrossRefGoogle Scholar

Copyright information

© Springer London 2010

Authors and Affiliations

  • Jean-Baptiste Ricco
    • 1
  • Olivier Page
  1. 1.Section of Vascular Surgery and Vascular InterventionUniversity of Poitiers Medical SchoolPoitiersFrance

Personalised recommendations